How I built the company with Semprus BioSciences CEO David Lucchino
Semprus BioSciences Corp. hopes to reduce the 60,000 deaths and $11 billion in costs related to "surface failures" of vascular catheters with its Sustain technology for coating medical devices.
DeviceTalks Podcast Network · DeviceTalks Podcast Network
June 11, 201319m 50s
Audio is streamed directly from the publisher (episodes.castos.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Semprus BioSciences Corp. hopes to reduce the 60,000 deaths and $11 billion in costs related to "surface failures" of vascular catheters with its Sustain technology for coating medical devices.
Topics
MassDevicemedicaltechnologyindustrymedicaldeviceindustrymedtech